의료용 M2M 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the healthcare m2M market size is expected to grow from USD 10.29 billion in 2025 to USD 11.60 billion in 2026 and is forecast to reach USD 22.63 billion by 2031 at 14.29% CAGR over 2026-2031.

This report is Segmented by Application (RPM, Telemedicine, Inpatient Monitoring, Clinical Operations, Asset Tracking, Medication Adherence), Connectivity (Cellular, LPWA, Wi-Fi, BLE, Zigbee, RFID), Component (Devices, Platforms, Services), End User (Hospitals, Homecare, Ascs, Diagnostic Centers), and Geography (North America, Europe, Asia-Pacific, MEA, South America). Forecasts are in USD Value.

Global Healthcare M2M Market Trends and Insights

Reimbursement Expansion For RPM/RTM And Virtual Care

Permanent U.S. CMS billing codes 99453-99458, and 98975-98981 convert what were pandemic-era pilot projects into predictable monthly revenue for providers. Private U.S. insurers mirror these codes, while France reimburses Dexcom ONE+ for insulin-treated Type 2 diabetes, prompting other EU payers to re-evaluate wearable coverage. India pilots RPM reimbursement under Ayushman Bharat to target rural hypertension, and initial data suggest per-patient monitoring costs fall below USD 5 per month.

Such policies upstream device demand and accelerate platform roll-outs that aggregate data into EHRs through FHIR interfaces. The upshot is a near-term boost in North America and a pipeline of adoption across Asia-Pacific once reimbursement frameworks mature.

Rising Chronic Disease Burden And Aging At-Home Care Needs

Japan's senior population hit 29.3% in 2024, and South Korea's reached 19.2%, straining institutional care capacity. India counts 62 million diabetes patients, with non-communicable diseases causing 52% of annual deaths. China processed 68 million county-level remote imaging cases in 2025, demonstrating how 5G links rural clinics to specialists. Low-cost LTE-M modules with 10-year batteries are now standard in glucometers and fall detectors, enabling continuous surveillance without burdensome power constraints. Collectively, demographic and epidemiologic pressures will propel sustained Healthcare M2M market growth throughout the forecast horizon.

Cybersecurity, Privacy, And Compliance Costs Across Expanded Attack Surface

The 2024 Change Healthcare ransomware event and Ascension Health breach revealed vulnerabilities in infusion pumps and telemetry hubs connected via M2M gateways. New FDA cybersecurity rules add USD 0.5-2 million to each platform's validation costs and compress launch timelines.

The EU's forthcoming Cyber Resilience Act introduces 24-hour incident reporting and third-party audits, compelling module vendors like Quectel to embed hardware root-of-trust mechanisms. Vendors lacking security budgets risk exclusion from hospital formularies, tempering near-term Healthcare M2M market growth.

Other drivers and restraints analyzed in the detailed report include:

1. Proliferation Of Connected Devices, Wearables, And Cloud/AI Analytics
2. Hospital Digitization for Operational Efficiency
3. Interoperability And Legacy Integration Complexity

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Remote Patient Monitoring (RPM) and connected medical devices still brought in a majority-share 56.14% of application revenue in 2025. Even so, Telemedicine & Virtual Care is set to expand the fastest, rising 16.56% annually through 2031. Several shifts explain the jump. First, Washington made pandemic telehealth waivers permanent, giving hospitals and clinics reliable reimbursement for behavioral health, chronic care, and specialty visits. Second, big public platforms prove that virtual care carries real weight. India's eSanjeevani, for example, has already logged 360 million visits, handling 7 out of 10 routine primary-care cases without requiring an office appointment.

Inside hospitals, wireless patient monitoring is spreading thanks to low-energy Bluetooth gear that lets a single nurse oversee more beds. Philips' long-term "equipment-as-a-service" deal with Hoag Hospital even bundles hardware, maintenance, and upgrades into a single subscription fee, turning hefty capital outlays into manageable operating costs. Although still small, medication-adherence tools are catching the eye of drug makers. ResMed's Propeller Health sensor clips onto an inhaler, time-stamps each puff, and pushes the data to the cloud-handy proof for asthma and COPD trial sponsors eager to show payers that patients really take their meds.

Classic cellular, 4G, LTE, and 5G, remains the largest slice, accounting for 37.91% of connectivity revenue in 2025, buoyed by smartphone ubiquity and the retirement of 2G/3G gear. Yet the brightest growth story belongs to short-range mesh protocols. Zigbee, Z-Wave, and Thread should grow 15.31% annually through 2031 as aging-in-place programs outfit homes with motion sensors, door contacts, and fall detectors. Matter, the interoperability standard finalized in 2024, lets a single hub pull data from assorted devices, smart speakers, lights, and glucose meters, without multiple gateways.

Governments with aging demographics are leaning in. Japan is subsidizing Thread-based fall sensors that alert caregivers within seconds, and South Korea has similar incentives. LTE-M and NB-IoT keep growing in low-power trackers and pill dispensers that send only a trickle of data but need batteries to last years. Wi-Fi still rules bedside monitors, but hospitals increasingly add private 5G layers for life-critical traffic because Wi-Fi 6E hand-offs can lag. Bluetooth Low Energy dominates wearables, and the new LE Audio spec even streams directly to hearing aids, blurring the line between medical and consumer tech.

Geography Analysis

North America accounted for 37.65% revenue in 2025, underpinned by CMS reimbursement clarity and dense private 5G pilots. Early outcomes from AdventHealth show notable reductions in nurse walking time, validating capital outlays and spurring copycat deployments. FDA cybersecurity rules raise entry barriers but also weed out sub-scale suppliers, nudging consolidation within the Healthcare M2M market. Canada and Mexico harmonize policies, creating a contiguous regulatory bloc that simplifies regional roll-outs.

Asia-Pacific is the fastest-growing theatre, with a 16.71% CAGR, propelled by China's 300 medical LLMs and India's 360 million-strong teleconsultation backbone. Japan and South Korea subsidize home-based monitoring to offset aging demographics, while 5G penetration across APAC reaches 18%, enabling edge AI at community clinics. Regional partnerships on quantum-AI cardiology trials hint at leapfrogging opportunities that could reorder vendor hierarchies.

Europe is growing steadily as MDR-mandated post-market surveillance makes embedded telemetry table stakes. Belgium and Finland prove sub-10 ms private 5G is feasible even in smaller hospitals, encouraging wider EU adoption. Middle-East Gulf states deploy kiosk-based telemedicine over 5G to remedy physician shortages, whereas South America's progress hinges on Brazil's subsidized data-plan program that targets Amazon basin chronic-disease hotspots.

1. Abbott Laboratories
2. Aeris Communications
3. AT&T
4. Boston Scientific
5. Cisco Systems
6. Dexcom
7. GE Healthcare
8. Insulet
9. Koninklijke Philips
10. KORE Wireless
11. Masimo
12. Medtronic
13. Microsoft Corporation (Azure IoT)
14. Oracle Health (Cerner)
15. Orange Business
16. Quectel Wireless Solutions
17. Resmed
18. Semtech (incl. Sierra Wireless)
19. Siemens Healthineers
20. Telefonica Tech
21. Telit Cinterion
22. u-blox
23. Verizon Communications Inc.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Reimbursement Expansion For RPM/RTM And Virtual Care
  • 4.2.2 Rising Chronic Disease Burden and Aging At-Home Care Needs
  • 4.2.3 Proliferation of Connected Medical Devices, Wearables, And Cloud/AI Analytics
  • 4.2.4 Hospital Digitization for Operational Efficiency (Patient Monitoring, Asset/Staff Tracking)
  • 4.2.5 Private 5G And Edge Deployments Enabling Deterministic Clinical Connectivity
  • 4.2.6 Decentralized Clinical Trials Integrating Regulated Sensor/eSource Data
• 4.3 Market Restraints
  • 4.3.1 Cybersecurity, Privacy, And Compliance Costs Across an Expanded Attack Surface
  • 4.3.2 Interoperability And Legacy Integration Complexity
  • 4.3.3 2G/3G Sunsets Driving Costly Migrations To LTE-M/NB-Iot
  • 4.3.4 Battery Longevity and Power Constraints in Medical Wearables/Implantable
• 4.4 Value Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts (Value, USD)

• 5.1 By Application
  • 5.1.1 Remote Patient Monitoring (RPM) and Connected Medical Devices
  • 5.1.2 Telemedicine & Virtual Care
  • 5.1.3 Inpatient Wireless Patient Monitoring
  • 5.1.4 Clinical Operations & Workflow Management
  • 5.1.5 Asset & Staff Tracking
  • 5.1.6 Medication Adherence & Connected Drug Delivery
  • 5.1.7 Other Applications
• 5.2 By Connectivity Technology
  • 5.2.1 Cellular (4G/LTE/5G)
  • 5.2.2 LPWA (LTE-M, NB-IoT)
  • 5.2.3 Wi-Fi
  • 5.2.4 Bluetooth Low Energy (BLE)
  • 5.2.5 Zigbee/Z-Wave/Thread
  • 5.2.6 RFID/NFC
• 5.3 By Component
  • 5.3.1 Medical Devices
  • 5.3.2 Platforms & Software
  • 5.3.3 Services
• 5.4 By End User
  • 5.4.1 Hospitals & Clinics
  • 5.4.2 Homecare Patients
  • 5.4.3 Ambulatory Surgical Centers
  • 5.4.4 Diagnostic & Imaging Centers/Labs
  • 5.4.5 Other End Users
• 5.5 By Geography
  • 5.5.1 North America
    • 5.5.1.1 United States
    • 5.5.1.2 Canada
    • 5.5.1.3 Mexico
  • 5.5.2 Europe
    • 5.5.2.1 Germany
    • 5.5.2.2 United Kingdom
    • 5.5.2.3 France
    • 5.5.2.4 Italy
    • 5.5.2.5 Spain
    • 5.5.2.6 Rest of Europe
  • 5.5.3 Asia-Pacific
    • 5.5.3.1 China
    • 5.5.3.2 India
    • 5.5.3.3 Japan
    • 5.5.3.4 South Korea
    • 5.5.3.5 Australia
    • 5.5.3.6 Rest of Asia-Pacific
  • 5.5.4 Middle East and Africa
    • 5.5.4.1 GCC
    • 5.5.4.2 South Africa
    • 5.5.4.3 Rest of Middle East and Africa
  • 5.5.5 South America
    • 5.5.5.1 Brazil
    • 5.5.5.2 Argentina
    • 5.5.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
  • 6.3.1 Abbott Laboratories
  • 6.3.2 Aeris Communications
  • 6.3.3 AT&T Inc.
  • 6.3.4 Boston Scientific Corporation
  • 6.3.5 Cisco Systems, Inc.
  • 6.3.6 Dexcom, Inc.
  • 6.3.7 GE HealthCare
  • 6.3.8 Insulet Corporation
  • 6.3.9 Koninklijke Philips N.V.
  • 6.3.10 KORE Wireless
  • 6.3.11 Masimo Corporation
  • 6.3.12 Medtronic plc
  • 6.3.13 Microsoft Corporation (Azure IoT)
  • 6.3.14 Oracle Health (Cerner)
  • 6.3.15 Orange Business
  • 6.3.16 Quectel Wireless Solutions
  • 6.3.17 ResMed Inc.
  • 6.3.18 Semtech (incl. Sierra Wireless)
  • 6.3.19 Siemens Healthineers AG
  • 6.3.20 Telefonica Tech
  • 6.3.21 Telit Cinterion
  • 6.3.22 u-blox
  • 6.3.23 Verizon Communications Inc.

7 Market Opportunities & Future Outlook

• 7.1 White-space & unmet-need assessment